Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Appili Therapeutics Inc. (APLIF) had Stock-Based Compensation of $0.02M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.08M |
|
$-0.72M |
|
-- |
|
$0.08M |
|
$1.02M |
|
$-0.94M |
|
$0.25M |
|
$-0.69M |
|
$-0.69M |
|
$-0.72M |
|
$-0.72M |
|
$-0.72M |
|
$-0.72M |
|
$-0.94M |
|
$-0.94M |
|
121.27M |
|
121.27M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.54M |
|
$0.01M |
|
$0.01M |
|
$0.55M |
|
$11.43M |
|
$0.44M |
|
$0.44M |
|
$11.88M |
|
$-11.33M |
|
$-11.33M |
|
$-11.33M |
|
121.27M |
|
| Cash Flow Statement Financials | |
$-0.56M |
|
-- |
|
$-0.09M |
|
$0.89M |
|
$0.25M |
|
$-0.64M |
|
|
Stock-Based Compensation |
$0.02M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.05 |
|
-- |
|
-- |
|
-0.04 |
|
-0.78 |
|
100.00% |
|
-1249.48% |
|
-1249.48% |
|
-- |
|
-917.98% |
|
-951.62% |
|
$-0.56M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
-- |
|
0.52 |
|
174.56 |
|
6.34% |
|
6.34% |
|
-131.10% |
|
6.59% |
|
$-0.09 |
|
$-0.00 |
|
$-0.00 |
|